Pricing Log in Create free account

BioStem Technologies, Inc. (BSEM) vs Pasithea Therapeutics Corp. (KTTA)

BioStem Technologies, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. BioStem Technologies, Inc. is the larger, with a market value of $19.4M against $17.4M — 1.1× the size. Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −76.0%) and the lower return on invested capital (−367.5% vs 55.3%). Across the 15 metrics below, BioStem Technologies, Inc. leads on 10 and Pasithea Therapeutics Corp. on 5.

Valuation

Metric BSEM KTTA Biotechnology median
P/E n/m n/m 10.60
P/S 0.56 38.26 9.40
P/B 0.70 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.68 1.17 0.66
EV/Sales 0.36 (55.79) 9.02
Earnings yield (137.92%) (254.86%) (32.88%)
Free cash flow yield 0.00% (94.76%) (23.13%)

Profitability

Metric BSEM KTTA Biotechnology median
Gross margin 91.16% 0.00% 68.51%
Operating margin 52.87% 0.00% 0.00%
Net margin (76.02%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (65.49%) (51.96%)
Return on assets 0.00% (61.97%) (46.06%)
Return on invested capital 55.34% (367.46%) 0.00%

Growth

Metric BSEM KTTA Biotechnology median
Revenue growth (TTM) (87.14%) — 6.76%
EPS growth (last fiscal year) (126.53%) 77.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BSEM KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 26.25 4.97
Net debt to EBITDA 0.00 2.74 1.01

Dividend

Metric BSEM KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM KTTA Biotechnology median
Market cap 19.42m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack